Dynavox delivered an in-line topline but a clear profitability beat in Q2, with the EBIT margin already above its 15% target.
Redeye comments on Dynavox’s Q2 report released earlier this morning.
Dynavox utvecklar kommunikationshjälpmedel för personer med nedsatt talförmåga.
We are maintaining our positive outlook on Dynavox Group following a Q1 performance that we view as a temporary "bump in the road".
Redeye comments on Dynavox’s Q1 report released earlier this morning, which delivered a solid start to the year despite being the company's ...
Redeye’s outlook on Dynavox remains stable after a record-breaking 2025, during which the company achieved exceptional growth with widesprea...
Redeye comments on Dynavox’s Q4 report released earlier this morning, which delivered another set of impressive results.
Redeye’s outlook on Dynavox remains stable after another strong report.
Redeye comments on Dynavox’s Q3 report released earlier this morning, which delivered solid results.
Redeye maintains a positive stance on Dynavox following another standout quarter.
Dynavox delivered another impressive report, with sales 8% above our forecast and 3% ahead of consensus, driven by 27% total growth (37% org...
Redeye maintains a positive view on Dynavox, which delivered another quarter of impressive growth, with 33% organic sales expansion and cont...
Dynavox delivered a robust Q1, with sales coming in 16% above our forecast and 13% ahead of consensus, driven by 36% total growth (33% organ...
Redeye comments on the acquisition announced this morning, where Dynavox Group acquires its long-time French partner Cenomy.
Redeye continues to see a compelling long-term investment case.
Redeye comments on the Q4 report released earlier this morning.
Redeye comments on the Q3 report released earlier this morning.
Redeye increase our growth expectations for the long term while making minor adjustments for the near term.
Redeye comments on the Q2 report released earlier this morning.
Redeye comments on yesterday’s news about Apple launching Eye tracking.
Redeye comments on the acquisition announced this morning, where Tobii Dynavox acquires the Australian and New Zealand-based companies Link ...
Redeye nudges our growth expectations for 2024e while slightly increasing costs.
Redeye comments on the Q1 report released earlier this morning.
Redeye alters the medium-term growth outlook on the back of a very upbeat CMD held by Tobii Dynavox last week.
Redeye views the performance of Tobii Dynavox favorably as the expectations continue to be exceeded.
Redeye adjusts our growth assumptions for the second half of 2023e based on strong organic growth outlook and the announced acquisition.
Redeye takes a positive stance on the news that Tobii Dynavox has entered into an agreement to acquire German Rehadapt, a worldwide provider...
Redeye adjusts our growth assumptions slightly for 2023e and beyond.
Redeye adjusts our growth assumptions for 2023e and beyond, the Q4 report increases our conviction in the long-term case.
Redeye is positively surprised by the better-than-expected Q4 report this morning.
Redeye slightly adjusts our expectations on 2023e based on the price adjustments made by CMS in the US and price increases in Europe.
Redeye makes small adjustments to our short-term estimates while increasing the conviction in the long-term case.
Redeye is impressed by the better-than-expected Q3 report this morning.
Redeye initiates coverage of Tobii Dynavox, a leading MedTech/tech company in the AAC (Augmentative and Alternative Communications) market.
